We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation. Third Harmonic Bio Inc is a clinical-stage company developing a novel oral approach to the treatment of severe allergy and inflammation.
SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal...
THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents totaling $296.1 million as of September 30, 2024 SAN...
SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal...
SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.82 | -19.7755960729 | 14.26 | 14.26 | 10.1 | 140571 | 12.02729828 | CS |
4 | -1.52 | -11.7283950617 | 12.96 | 15.5 | 10.1 | 218216 | 13.72433567 | CS |
12 | -0.54 | -4.50751252087 | 11.98 | 16.02 | 10.1 | 215541 | 13.47137007 | CS |
26 | -2.96 | -20.5555555556 | 14.4 | 16.94 | 10.1 | 140805 | 13.29007837 | CS |
52 | 4.65 | 68.4830633284 | 6.79 | 16.94 | 6.79 | 144007 | 11.7889639 | CS |
156 | -29.43 | -72.0088084169 | 40.87 | 40.87 | 3.75 | 113662 | 9.31409839 | CS |
260 | -29.43 | -72.0088084169 | 40.87 | 40.87 | 3.75 | 82594 | 9.31409839 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions